2019 Assay Development Clinical Development Pharmacokinetics 
Drug Discovery World
FEBRUARY 15, 2023
The number of new cases recorded between 2016 and 2018 was 375,400, with 167,142 deaths caused by cancer between 2017 and 2019. These models have greatly contributed to the clinical development of several tumour immunotherapies. Great strides have been made in this journey during the last decade.
Agency IQ
FEBRUARY 2, 2024
EMA finalizes clinical anticancer therapeutic guidance update In a newly finalized revision, the EMA’s guideline covering all aspects of clinical development of anticancer therapeutics has expanded its already broad scope. In 2019 more than one in four (28%) of deaths in the E.U. after ischemic heart disease and stroke.
Expert insights. Personalized for you.
130 
Let's personalize your content